Rebecca Spence

1.3k total citations
32 papers, 855 citations indexed

About

Rebecca Spence is a scholar working on General Health Professions, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Rebecca Spence has authored 32 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in General Health Professions, 13 papers in Public Health, Environmental and Occupational Health and 5 papers in Molecular Biology. Recurrent topics in Rebecca Spence's work include Patient-Provider Communication in Healthcare (8 papers), Ethics in Clinical Research (6 papers) and Palliative Care and End-of-Life Issues (6 papers). Rebecca Spence is often cited by papers focused on Patient-Provider Communication in Healthcare (8 papers), Ethics in Clinical Research (6 papers) and Palliative Care and End-of-Life Issues (6 papers). Rebecca Spence collaborates with scholars based in United States, France and United Kingdom. Rebecca Spence's co-authors include Kenneth A. Johnson, Karen S. Anderson, Warren M. Kati, Angela R. Bradbury, Reshma Jagsi, Linda M. Sweeting, Rochelle D. Jones, Christopher D. Cox, Arnold L. Rheingold and Raymond De Vries and has published in prestigious journals such as Science, Journal of Clinical Oncology and Chemistry of Materials.

In The Last Decade

Rebecca Spence

32 papers receiving 816 citations

Peers

Countries citing papers authored by Rebecca Spence

Since Specialization

Citations

This map shows the geographic impact of Rebecca Spence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Spence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Spence more than expected).

Fields of papers citing papers by Rebecca Spence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Spence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Spence. The network helps show where Rebecca Spence may publish in the future.

Co-authorship network of co-authors of Rebecca Spence

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Spence. A scholar is included among the top collaborators of Rebecca Spence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Spence. Rebecca Spence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers 2025 ·Journal of Clinical Oncology ·Eric P. Winer, Laura A. Levit, Ethan Basch, Mariana Chávez‐MacGregor, Raymond N. DuBois, S. Gail Eckhardt, L. M. Ellis, Clifford A. Hudis, Deborah Schrag, Corey Speers, Breelyn A. Wilky, (unknown), Rebecca Spence, Elizabeth Garrett‐Mayer	2
2	State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023 2025 ·PubMed ·Caroline Schenkel, Laura A. Levit, M. Kelsey Kirkwood, Rebecca Spence, John M. Burke, Colleen M. Gallagher, Elizabeth Garrett‐Mayer, (unknown), (unknown), Ray D. Page, Judith A. Paice, Eric D. Tetzlaff, Eric P. Winer, Fay J. Hlubocky, Tait D. Shanafelt	4
3	Development, Feasibility, and Acceptability of an Oncologist Group Peer Support Program From ASCO's Clinician Well-Being Task Force 2023 ·JCO Oncology Practice ·Fay J. Hlubocky, Daniel C. McFarland, Anthony L. Back, Christopher R. Friese, Laurie Lyckholm, Colleen M. Gallagher, (unknown), Rebecca Spence, Laura Lynch, (unknown), Tait D. Shanafelt, Piyush Srivastava	1
4	Health Data Sharing Perspectives of Patients Receiving Care in CancerLinQ-Participating Oncology Practices 2023 ·JCO Oncology Practice ·Reshma Jagsi, Krithika Suresh, Chris Krenz, Rochelle D. Jones, Kent A. Griffith, (unknown), Sarah T. Hawley, Brian J. Zikmund‐Fisher, Kayte Spector‐Bagdady, Jodyn Platt, Raymond De Vries, Angela R. Bradbury, Pranshu Bansal, (unknown), (unknown), Richard L. Schilsky, Robert S. Miller, Rebecca Spence	3
5	ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages 2023 ·Journal of Clinical Oncology ·Andrew Hantel, Rebecca Spence, (unknown), Angela R. Bradbury, Avram Denburg, Reshma Jagsi, Beverly Moy, W. Kimryn Rathmell, Abby R. Rosenberg, Banu Symington, Jonathan M. Marron, Jeffrey Peppercorn	5
6	ASCO Ethical Guidance for the US Oncology Community Where Reproductive Health Care Is Limited by Law 2023 ·Journal of Clinical Oncology ·Rebecca Spence, Leslie Hinyard, Reshma Jagsi, Rachel Jimenez, Ana Mariá López, Mariana Chávez‐MacGregor, Kayte Spector‐Bagdady, Abby R. Rosenberg	3
7	The state of workforce retention among US oncologists. 2023 ·JCO Oncology Practice ·Caroline Schenkel, Laura A. Levit, (unknown), Rebecca Spence, Fay J. Hlubocky, Anthony L. Back, John M. Burke, Christopher R. Friese, Colleen M. Gallagher, Laurie Lyckholm, Ray D. Page, Judith A. Paice, Eric D. Tetzlaff, (unknown), (unknown), Tait D. Shanafelt	1
8	The state of professional wellbeing and satisfaction among US oncologists. 2023 ·JCO Oncology Practice ·Caroline Schenkel, Laura A. Levit, (unknown), Rebecca Spence, Fay J. Hlubocky, Anthony L. Back, John M. Burke, Christopher R. Friese, Colleen M. Gallagher, Laurie Lyckholm, Ray D. Page, Judith A. Paice, Eric D. Tetzlaff, (unknown), (unknown), Tait D. Shanafelt	3
9	Occupational and Personal Consequences of the COVID-19 Pandemic on US Oncologist Burnout and Well-Being: A Study From the ASCO Clinician Well-Being Task Force 2021 ·JCO Oncology Practice ·Fay J. Hlubocky, Anthony L. Back, Tait D. Shanafelt, Colleen M. Gallagher, John M. Burke, Arif H. Kamal, Judith A. Paice, Ray D. Page, Rebecca Spence, (unknown), Daniel C. McFarland, Piyush Srivastava	28
10	Now, More Than Ever, Is the Time for Early and Frequent Advance Care Planning 2020 ·Journal of Clinical Oncology ·Abby R. Rosenberg, Beth Popp, Don S. Dizon, Areej El‐Jawahri, Rebecca Spence	8
11	Prognostication and Communication in Oncology 2019 ·Journal of Oncology Practice ·Thomas W. LeBlanc, Jonathan M. Marron, Sabha Ganai, (unknown), Rebecca Spence, (unknown), William D. Tap, Fay J. Hlubocky	9
12	Let’s Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine 2019 ·Journal of Oncology Practice ·(unknown), Fay J. Hlubocky, Charles D. Blanke, Thomas W. LeBlanc, Jonathan M. Marron, (unknown), Rebecca Spence, Lynne P. Taylor	14
13	Discrepancies in Financial Self-Disclosures and Open Payments Reporting Among Authors of Clinical Oncology Research Studies 2019 ·Journal of Clinical Oncology ·Elizabeth Garrett‐Mayer, (unknown), Rebecca Spence, Suanna S. Bruinooge, Clifford A. Hudis, (unknown), Richard L. Schilsky	4
14	Ethical Considerations for the Clinical Oncologist in an Era of Oncology Drug Shortages 2014 ·The Oncologist ·Reshma Jagsi, Rebecca Spence, W. Kimryn Rathmell, Angela R. Bradbury, Jeffrey Peppercorn, (unknown), Beverly Moy	13
15	Abandoning Women to Their Rights: What Happens When Feminist Jurisprudence Ignores Birthing Rights 2012 ·eYLS (Yale Law School) ·Rebecca Spence	2
16	Lysine164α of protein farnesyltransferase is important for both CaaX substrate binding and catalysis 2001 ·Biochemical Journal ·Kendra E. Hightower, (unknown), Carolyn Weinbaum, Rebecca Spence, Patrick J. Casey	9
17	Lysine164α of protein farnesyltransferase is important for both CaaX substrate binding and catalysis 2001 ·Biochemical Journal ·Kendra E. Hightower, (unknown), Carolyn Weinbaum, Rebecca Spence, Patrick J. Casey	8
18	Section Reviews; Anti-infectives: Section Review Anti-infectives: Therapeutic potential of nonnucleoside reverse transcriptase inhibitors in the treatment of HIV infection 1996 ·Expert Opinion on Investigational Drugs ·Rebecca Spence, Kenneth A. Johnson	2
19	HIV-1 Reverse Transcriptase Resistance to Nonnucleoside Inhibitors 1996 ·Biochemistry ·Rebecca Spence, Karen S. Anderson, Kenneth A. Johnson	63
20	Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside Inhibitors 1995 ·Science ·Rebecca Spence, Warren M. Kati, Karen S. Anderson, Kenneth A. Johnson	411

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact